Specify a stock or a cryptocurrency in the search bar to get a summary
Medicon Hellas S.A.
MEDICMedicon Hellas S.A. operates in the diagnostics industry. The company offers instruments, tests, and procedures for public and private hospitals, primary care centers, diagnostic centers, and private laboratories in Greece and internationally. The company distributes various analyzer sysytem for chemistry, immunochemistry and hematology labs, intensive care units, and point-of-care systems. It also produces reagents for various analyzers, such as specific protein and hematology, as well as clinical chemistry reagents comprising control and calibration materials, and tests. In addition, the company engages in the production of cosmetic and skin care products under the Miss Beaute brand name. Further, it develops and sells software for laboratory and medical applications, and supplies IT systems to healthcare providers. Additionally, the company remanufactures and resells chemistry, hematology, blood gas, and immunochemistry analyzers; and provides contract remanufacturing and diagnostics laboratory services. Medicon Hellas S.A. was founded in 1988 and is headquartered in Gerakas, Greece. Address: 5-7 Melitona Street, Gerakas, Greece, 153 44
Analytics
WallStreet Target Price
–P/E ratio
13.4503Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures MEDIC
Dividend Analytics MEDIC
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
27 %Dividend History MEDIC
Stock Valuation MEDIC
Financials MEDIC
Results | 2019 | Dynamics |